RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

116 hedge funds and large institutions have $870M invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.36M
Puts
$13.9M
Net Calls
Net Calls Change

Top Buyers

1 +$37.2M
2 +$20.9M
3 +$17.9M
4
RI
RTW Investments
New York
+$12.2M
5
SI
Sofinnova Investments
California
+$10.9M

Top Sellers

1 -$21.4M
2 -$14.2M
3 -$11.3M
4
BlackRock
BlackRock
New York
-$9.71M
5
DTC
Deep Track Capital
Connecticut
-$9.25M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$337K
77
$332K
78
$323K
79
$321K
80
$304K
81
$294K
82
$283K
83
$282K
84
$280K
85
$251K
86
$251K
87
$245K
88
$230K
89
$223K
90
$208K
91
$158K
92
$145K
93
$131K
94
$117K
95
$100K
96
$79K
97
$78K
98
$65K
99
$63K
100
$50.6K